Sep
21
2022
On demand
Accelerating immuno-oncology innovation using humanized mouse models
Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
Join us for this very exciting webinar where we discuss some of the most valuable immunology and oncology research tools available to date: humanized mouse models. Learn how these robust, translationally relevant mouse models are rapidly changing preclinical drug development in ways we never thought possible.
- Humanized components of the immune/oncology checkpoint pathways
- Models for bi-specific antibody development
- Next generation immunodeficient mice (NCG) for xenografts and better stem cell engraftment
SPEAKERS
You might also like
Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME
Emily Neil, Ariadna Pascual
27 June
in 69
Days
Pure and simple: understanding LNP analytics for better mRNA-based drugs
Adam Crowe
29 May
in 40
Days
Empowering patient care: in-process and quality control solutions for cellular therapies
Christin Tischner, Simon Lennartz
23 May
in 34
Days
T cells from beginning to end: optimizing leukopak and drug product cryopreservation
Meredith Safford, ShaNelle Yelity
22 May
in 33
Days
Mastering AAV production: best practices For small- to large-scale manufacturing success and reduced development time
Emily Jackson-Holmes
21 May
in 32
Days